Elon Musk’s latest Texas-sized ambition is to build his own AI chip empire, and this time the factory floor will sit right next to the robots, rockets, and robotaxis that plan to use it. The Terafab project, a new semiconductor venture linking…
GeoVax Labs (NASDAQ: GOVX), a clinical-stage biotechnology company, has recently sharpened its focus on addressing urgent global health threats through advanced vaccine development and manufacturing strategies. Since October, the Atlanta-based firm has released a series of statements highlighting regulatory wins, key interim…
Eli Lilly’s (LLY) relentless push into obesity and diabetes therapeutics is reshaping the future of metabolic health—and igniting a wave of innovation among smaller device makers intent on redefining patient care at home. Building on strong demand for its blockbuster weight-loss and…
Nokia’s (NOK, $6.11, +37.85% YTD) latest earnings report suggests the Finnish telecom and technology company is undergoing one of its most compelling transformations in years—pivoting decisively toward AI infrastructure and cloud networking as new revenue engines drive growth and boost investor confidence.…
Intuitive Surgical (NASDAQ: ISRG) delivered a striking third quarter, sending its shares surging 17% on Wednesday and underscoring both the company’s operational strength and the accelerating global embrace of robotic-assisted healthcare. The Sunnyvale, California-based leader in minimally invasive surgery reported quarterly revenue…
Serina Therapeutics (NYSE American: SER) CEO Steven A. Ledger shared encouraging insights in a recent video presentation about the company’s accelerated FDA regulatory pathway for its lead asset, SER-252, targeting advanced Parkinson’s disease. The video can be viewed here: Serina CEO FDA Alignment…
Alkermes (ALKS) is making a bold entry into the sleep disorders market with the acquisition of Avadel Pharmaceuticals, a deal valued at up to $2.1 billion. This strategic move gives Alkermes access to LUMRYZ, a once-nightly, FDA-approved treatment for narcolepsy, and sets…
Japanese pharmaceutical giant Takeda Pharmaceutical (TAK) has entered into one of the industry's largest licensing agreements this year, committing up to $11.4 billion to acquire rights to three next-generation cancer therapies from China's Innovent Biologics in a deal that underscores the growing…
Tesla (TSLA) is set to report its third-quarter 2025 earnings today, a report that could serve as a major inflection point for the world’s most prominent electric-vehicle maker. Analysts anticipate revenue near 26.3 billion dollars and earnings per share (EPS) of roughly…
Blackstone (BX) and TPG (TPG) are taking women’s health leader Hologic Inc. (HOLX) private in one of the largest healthcare buyouts of 2025, valuing the Massachusetts-based company at up to $18.3 billion including debt. The all-cash deal, announced Tuesday, will pay Hologic…